Replies to post #129830 on OWC Pharmaceutical Research Corp (OWCP)

[EasternTimeZone]

$OWCP could easily reach $5 in 2018.

This is BUY OPPORTUNITY:
Management reminded today they are aligned with shareholders and they HOLD LONG TERM their shares, they didn't sell at 3.23$ and they are CONFIDENT we will recover that value and higher in long term!
No dilution!
Cash on hands for 2018!
Only one direction for share we skyrocket from 0.40 and the direction is 1B market cap!
Did you notice that the Neuroderm sold to for 1B at 39$ PPS was having a couple of products between phase 1 and phase 2?
Which means OWCP after phase 1 and safety trial completed for canapsor should be fairly valued 5-10$ PPS !! Adding that they will sell it before as cosmetic generating revenue... And you see this is just a BUY